Breath Therapeutics, a Zambon company

📍 Munich, Germany🗓 Founded 2016👥 17 employees💰 Last funded Mar 2017
Biotechnology🌐 breath-therapeutics.com
Website LinkedIn
People living with rare lung disorders are at the center of everything we do. Breath Therapeutics, a Zambon company is a private clinical-stage biopharmaceutical company specializing in advanced inhaled therapies for severe respiratory diseases with high unmet medical need. By combining novel formulations of existing drugs with cutting-edge inhalation technology to rapidly deliver high concentrations of drugs to the site of action in the lung, the company is unleashing the true potential of inhaled drug delivery. This approach increases effective dosing in the lung while minimizing systemic exposure which could lead to new treatment solutions with enhanced efficacy and safety. The Company’s pivotal late-stage program, BOSTON, is evaluating L-CsA-i, the first potential therapy for bronchiolitis obliterans syndrome (BOS), a devastating lung disease with very high mortality that commonly affects patients who have received lung or allogeneic hematopoietic stem cell transplantation. Breath Therapeutics is also evaluating a second clinical development program utilizing its drug-device innovation to address the unmet medical need in additional orphan respiratory diseases. Breath Therapeutics, a Zambon company has offices in Munich, Germany and Menlo Park, CA. For more informationPlease visit https://breath-therapeutics.com/forward-looking-disclaimer/ for forward-looking statements disclaimer.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
2
Frequently asked questions
Who invested in Breath Therapeutics, a Zambon company?
Breath Therapeutics, a Zambon company has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Breath Therapeutics, a Zambon company last raise funding?
The most recent investment in Breath Therapeutics, a Zambon company recorded on gritt.io was in March 2017.
When was Breath Therapeutics, a Zambon company founded?
Breath Therapeutics, a Zambon company was founded in 2016.
What industry is Breath Therapeutics, a Zambon company in?
Breath Therapeutics, a Zambon company operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Breath Therapeutics, a Zambon company based?
Breath Therapeutics, a Zambon company is headquartered in Munich, Germany.